HLA-A and toxic epidermal necrolysis: In order to evaluate the susceptible and protection effect of HLA-A*02:06:01 and HLA-A*24:02:01, we compared the frequencies of CM-SJS/TEN with SOCs patients and healthy controls carrying both HLA-A*02:06:01 and HLA-A*24:02:01.